Our findings point to PKCε as a FGFR2c-specific signaling substrate in epithelial cells, which we have demonstrated not to be activated by other FGFRs physiologically expressed by normal epithelial contexts (such as FGFR2b) [6], often exerting tumor-suppressive roles in cancer. The gene discussed is PRKCE; the disease is neoplasm.